Scopus BioPharma Inc. (SCPS)
OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
At close: Oct 15, 2026
Scopus BioPharma Market Cap
Scopus BioPharma has a market cap or net worth of $16.83 thousand as of October 20, 2026. It is the 51,644th most valuable company in the world and the 7,670th biggest in the United States. Its market cap has increased by 33.34% in one year.
Market Cap
16.83K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#7,670 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since December 16, 2020, Scopus BioPharma's market cap has decreased from 85.70M to 16.83K, a decrease of -99.98%. That is a compound annual growth rate of -76.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 16.83K | - |
| Dec 31, 2025 | 16.83K | 33.34% |
| Dec 31, 2024 | 12.63K | -99.30% |
| Dec 29, 2023 | 1.81M | -11.91% |
| Dec 30, 2022 | 2.06M | -94.04% |
| Dec 31, 2021 | 34.49M | -83.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Burzynski Research Institute | 26.29K |
| Biostax | 21.65K |
| Health Sciences Group | 20.51K |
| Anebulo Pharmaceuticals | 16.31K |
| Bio-Path Holdings | 16.17K |
| Vaxxinity | 12.68K |
| ObsEva | 11.72K |
| Syros Pharmaceuticals | 10.73K |